10x Genomics (NASDAQ:TXG) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
10x Genomics missed estimated earnings by 22.58%, reporting an EPS of $-0.38 versus an estimate of $-0.31.
Revenue was up $8.68 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.07 which was followed by a 14.73% drop in the share price the next day.
Here's a look at 10x Genomics's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|
| EPS Estimate | -0.31 | -0.09 | -0.20 | -0.26 | -0.27 |
| EPS Actual | -0.38 | -0.16 | -0.15 | -0.10 | -0.11 |
| Revenue Estimate | 113.34M | 148.53M | 122.62M | 112.85M | 102.51M |
| Revenue Actual | 114.50M | 143.53M | 125.30M | 115.84M | 105.82M |
To track all earnings releases for 10x Genomics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
